BanEnz - Complete Water and Wastewater Solutions

The school of Vedic studies

Shipping, Logistics and Software solutions

Quote from BagvadGita

For him who has conquered the mind, the mind is the best of friends; but for one who has failed to do so, his mind will remain the greatest enemy.

You may donate now



By D. Kaffu. Westwood College Georgia. 2018.

Clinical trials in Chinese medicine – REFERENCES the efficacy driven approach generic 17.5 mg lisinopril fast delivery. NIH Consensus Statement Origin: Chemistry buy discount lisinopril 17.5mg online, Pharmacology and Use in (1997) 15(5): 1–34 order 17.5mg lisinopril free shipping. Berlin: Sprin- tional medicine in the USA – prevalence, costs ger-Verlag, (1996). Introducing a placebo ting up and running a pharmacovigilance centre needle into acupuncture research. Ascertaining the minimally important differ- theory of acupuncture in musculoskeletal pain. On the evaluation of the evance and statistical significance in health related clinical effects of acupuncture. Causes and treatment of low back status and well-being of patients with chronic pain. Green  2004 John Wiley & Sons, Ltd ISBN: 0-471-98787-5 6 B reast ancer DONALD A. Anderson Cancer Center, Houston, TX 77030, USA INTRODUCTION in situ (DCIS) increased by about sixfold, from about 5 cases per 100 000 women in 1980 to more More than 200 000 women in the United States than 30 per 100 000 in 1998. About Despite the increasing incidence of breast 40 000 women die from the disease each year. Although the risk mortality has decreased by almost 2% per year of breast cancer is substantially higher in older in the 1990s. Of this improvement in breast cancer survival to cases diagnosed in the US in 1998, 5% occurred increased use of screening mammography and to in women under the age of 35, 30% in women improvements in the treatment of breast cancer. These years saw the for- From 1940 to the early 1980s, breast cancer mation of strong advocacy groups that worked incidence in the US increased by a fraction to promote research in breast cancer. In addition, patient advocates the same period, the rate of ductal carcinoma have become highly educated about research Textbook of Clinical Trials. Green  2004 John Wiley & Sons, Ltd ISBN: 0-471-98787-5 88 TEXTBOOK OF CLINICAL TRIALS issues and many serve regularly alongside profes- 0 through Stage IV disease are 21%, 42%, 29%, sional scientists on various governmental boards 5% and 4%, respectively. Patient advo- examination has limited discrimination ability cates also serve on cooperative group committees because 70–80% of tumours are of a single type: that plan clinical trials in breast cancer, institu- infiltrating ductal carcinoma. PROGNOSIS Advocacy groups have worked to increase the number of women who participate in clinical tri- Breast cancer is heterogeneous. The Clinical Trial Initiative of the National cancers are slowly growing and their carriers Breast Cancer Coalition Fund (NBCCF) main- survive for many years and die of other causes. This heterogeneity registry, experts from the NBCCF ascertain that has implications for research in all phases of the it addresses an important, novel research ques- disease, beginning with screening and diagnostic tion related to breast cancer, and that its design methods through the evaluation of treatments for is scientifically rigorous and employs appropriate advanced disease. Stage IV disease is generally regarded to be incurable, with median STAGING survival in the range of 18 to 24 months, although a small fraction of patients with Stage IV disease Breast cancer is staged using a system developed achieve complete remission following systemic by the American Joint Committee on Cancer, chemotherapy, and survive for many years. The stage of disease, ranging from 0 node involvement is associated with a worse to IV, is based on combinations of these TNM prognosis, with five-year disease-free rates rang- rankings. Tumour grade, proliferative Stage 0 consists of ductal and lobular carci- activity and menopausal status play relatively noma in situ (DCIS, LCIS), non-invasive and minor roles. Although stage is an important prognostic Stages I to III are invasive stages in which the factor, it is of limited use as a determinant tumour is confined to the breast or its immedi- of treatment outcome. Higher stage indicates larger primary of treatment are reasonably consistent across tumours or greater locoregional tumour involve- stages – although the absolute benefit can be ment. Patients having evidence of distant metas- much greater for higher stage disease. In the US, the approxi- as indicators of general tumour aggressiveness, mate proportions of women diagnosed with Stage irrespective of type of therapy. BREAST CANCER 89 The best-studied predictive factor is oestrogen- breast cancer throughout the first half of the cen- receptor (ER) status, which is an important tury, sometimes combined with radiotherapy. Tamoxifen and other selec- clinical trials to investigate alternative therapies tive oestrogen-receptor modulators (SERMs) are was proposed in the 1960s, controversy arose highly effective in patients with hormone- among breast cancer researchers as well as in sensitive breast cancer, but they have no other medical fields. Patients who benefit from SERMs pioneers in the field persisted in designing tri- may also benefit from aromatase inhibitors. These early tri- 20% to 40% of breast tumours, and has been als compared various surgical and radiotherapy cited in numerous reports as conveying poor approaches. Rather, breast cancer came to be understood as a systemic disease that HISTORICAL PERSPECTIVE ON CLINICAL could benefit from systemic therapy, and radi- TRIALS IN BREAST CANCER cal local therapies were no longer regarded as essential for prolonging survival.

Doing so would be important only if these are not trivial 17.5 mg lisinopril otc, since neither the most impor- there are serious questions about whether patients tant questions generic 17.5mg lisinopril with mastercard, nor the best way to approach a in such settings respond to proven treatments best lisinopril 17.5 mg. ANXIETY DISORDERS 257 If this is the case, it is important to frame research will be conducted and in how many the specific questions the study should answer, different kinds of settings. Likewise, some patients have who do not seek treatment in a research clinic? Or, the research aim might focus on sense to recruit patients from medical clinics into evaluating alternative screening strategies in dif- an efficacy trial in order to study the influence ferent settings. Alternatively, the investigators might considerations like these ought to drive the examine the effect of different organisational important design decisions such as where the structures or the impact of the organisational Table 17. Implications of features of anxiety disorders for research design Feature Research issues 1. Poorly defined nosologic boundaries Normal vs disordered: a question of excess Differential diagnosis: core symptoms overlap Pluripotency: treatments with broad efficacy Double counting: symptoms Endpoints: ranking outcomes Aiming low: focus on preventing relapse Stability: the time frame for outcome 3. Phobic fear and avoidance Evasion: measuring the avoidant subject Fear: recruiting the anxious subject Identification: personal choice vs avoidance 4. Discordant models of the disorders Acknowledgement: both models have treatment successes Control: paying attention to the other intervention Comparing: accommodating preference for modality Targets: agreeing on the goals Dissemination: thinking ahead about the audience 258 TEXTBOOK OF CLINICAL TRIALS climate5 on outcomes or study the implementa- non-traditional research settings will tax the inge- tion of organisational interventions to optimise nuity of the next generation of effectiveness the likelihood of dissemination of a treatment. Recent work using adaptive testing Whatever studies are done, it is clear that for methods holds promise as a technique. Given anxiety disorders, researchers need to extend their these challenges, it is tempting to suggest that reach if they seek to make an impact on the great researchers concentrate on one research setting, majority of individuals who suffer from these and hope or assume that results will generalise. Methods need to be devised to study But the decision to limit the setting has uncer- patients in primary care and specialty medical tain implications for interpreting and generalising settings, dental offices, churches, schools, com- results. There is a trade-off between generalis- munity centres, and a range of other community ability and the cost of dealing with heterogeneity service or support settings (e. These costs must be borne, and the lence or homeless shelters, or even highly utilised methodological challenges met, in order to pro- commercial operations such as supermarkets7 or duce research-grade answers to the question of department stores). Designing a new clinical trial for an anxi- Researchers need to take steps to minimise the ety disorder outside of an established research difficulties that may be caused by identifying a centre raises other problems. Investigators make person as ill, especially when the person in ques- deliberate decisions about where to recruit, assess tion has not already identified their symptoms as and treat patients, as well as whether to carry problematic. In such a situation, the news may out any of these activities in more than one come as an unwelcome surprise, or may be per- kind of setting. The newly ods for recognising and recruiting affected indi- diagnosed individual may feel suddenly stigma- viduals may be too cumbersome to work in a tised and this may lead to a rejection of the setting where research activities are not custom- diagnosis and/or the researcher bearing the news. For example, a busy primary care practice or There may be anger or discouragement towards even a mental health facility may not be oriented the community setting in which the person sought towards identifying and tracking individuals who help. The researcher needs to be sensitive to these meet criteria for anxiety disorders. Frequently possibilities and proactive in dealing with unto- staff in such places are very busy, very dedi- ward reactions associated with identification of cated and sometimes opinionated about what is an anxiety disorder. The researcher who comes decision to recruit subjects in a non-psychiatric to study usual practice may be seen as challeng- setting such as a church or supermarket, the ing the skills, competence or even integrity of the researcher would need to include an introductory staff. Still, recent studies in primary care8 have phase of the work that addresses fears and stigma succeeded in overcoming these barriers and have associated with a diagnosis. This can be done in a done much to provide information to inform pro- variety of ways. Individual or group consciousness raising riers to acceptance in settings other than the might be offered. Assessment of outcomes is hard strategy being increasingly used by researchers. Thus armed, the researcher careful, reliable descriptions of different well- will be more successful in recruiting and retaining specified phenotypes of psychiatric illness. An example of a very highly successful in meeting this goal, such innovative approach to the problem of commu- instruments have not been designed to maximise nity recruitment9 utilised an intensive telephone efficiency and minimise patient and staff burden.

discount 17.5 mg lisinopril with visa

This publication is designed to provide accurate and authoritative information in regard to the subject matter covered generic 17.5mg lisinopril amex. It is sold on the understanding that the Publisher is not engaged in rendering professional services cheap 17.5mg lisinopril overnight delivery. If professional advice or other expert assistance is required discount lisinopril 17.5mg amex, the services of a competent professional should be sought. Some content that appears in print may not be available in electronic books. Library of Congress Cataloging-in-Publication Data Textbook of clinical trials / edited by David Machin. BHATTACHARYA Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, Cronhill Road, Aberdeen AB25 2ZD, UK, Email: s. Anderson Cancer Centre, Texas, USA SIMON DAY Licensing Division, Medicines and Healthcare products Regulatory Agency, Room 13-205 Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK, Email: simon. LEUNG Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Room 74026, 5th Floor, Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong, Email: pingcleung@cuhk. LIU SWOG Statistical Centre, MP 557, Fred Hutchinson Cancer Research Centre, 1100 Fairview Avenue North, PO Box 19024, Seattle, WA 98109 1024, USA, Email: pyl@swog. ELEANOR SCHRON National Heart, Lung, and Blood Institute, Bethesda, MD 20892 2482, USA, Email: schrone@nhlbi. SONDAK University of Michigan Medical Centre, Division of Surgical Oncology, 1500 E Medical Centre Drive, 3306 Cancer/Geriatrics Ctr Box 0932, Ann Arbor, MI 48109 0932, USA, Email: vsondak@umich. WONG Dental Public Health, Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Hong Kong, Email: mcmwong@hkucc. The latter has evolved in many ways ple are – in some sense – based more on expe- through the direct needs of clinical trials and the rience. Other important statistical developments consequent interaction of statistical and clinical have not depended on technical advancement, disciplines. The impact of the results from clin- but rather on conceptual advancement, such as the now standard practice of reporting confidence ical trials, particularly the randomised controlled intervals rather then relying solely on p-values trial, on the practice of clinical medicine and at the interpretation stage. In over this same time period has been the expansion particular, they have provided the essential under- in data processing capabilities and the range of pinning to evidence-based practice in many disci- analytical possibilities only made possible by the plines and are one of the key components for reg- tremendous development in computing power. Thus, as we write, SARS has tion for the science of clinical trial research and emerged: the final extent of the epidemic placed the medical statistician at the centre of the is unknown, diagnosis is problematical and process. Although the medical statistician may be no specific treatment is available. Advances in medical the outcome cosmetic then a more conservative and associated technologies are not confined approach to treatment options would be justified. Clinical trials imply some intervention affect- Thus the Textbook of Clinical Trials addresses ing the subjects who are ultimately recruited into some of these and many other issues as they them. These subjects will range from the very impact on patients with cancer, cardiovascular healthy, perhaps women of a relatively young age disease, dermatological, dental, mental and oph- recruited to a contraceptive development trial, thalmic health, gynaecology and respiratory dis- to those (perhaps elderly) patients in terminal eases. In addition, chapters deal with issues relat- decline from a long-standing illness. Each group ing to complementary medicine, contraception studied in a clinical trial, from unborn child to and special issues in children and special issues aged adult, brings its own constraint on the ulti- in older patients. So too does the als and a summary of some pertinent statistical relative efficacy of the current standard. If the disease is self-limiting or David Machin, Simon Day and Sylvan Green IN TR O U TIO N Textbook of Clinical Trials. Green  2004 John Wiley & Sons, Ltd ISBN: 0-471-98787-5 1 B rief istory of linical Trials 1 2 S. EDERER 1Licensing Division, Medicines and Healthcare products Regulatory Agency, London, UK 2The EMMES Corporation, Rockville, MD 20850, USA The modern-day birth of clinical trials is usually Daniel lived around the period 800BC and although considered to be the publication in 1948 by it may not be possible to confirm the accuracy the UK Medical Research Council1 of a trial of the account, what is clear is that when this for the treatment of pulmonary tuberculosis with passage was written–around 150BC–the ideas streptomycin. The comparative The passage from Daniel describes not just a concept of assessing therapeutic efficacy has control group, but a concurrent control group.

cheap 17.5mg lisinopril free shipping

Absorption is inhibited by vitamin D phorus are ingested in approximately equal amounts buy lisinopril 17.5 mg online. Because this deficiency; a high-fat diet; the presence of oxalic acid (from beet equal ratio is present in milk lisinopril 17.5mg overnight delivery, milk is probably the best source of greens discount 17.5 mg lisinopril overnight delivery, chard), which combines with calcium to form insoluble cal- phosphorus. In general, factors that increase or decrease calcium cium oxalate in the intestine; alkalinity of intestinal secretions, absorption act the same way on phosphorus absorption. Vitamin D which leads to formation of insoluble calcium phosphate; diarrhea enhances, but is not essential for, phosphorus absorption. Large or other conditions of rapid intestinal motility, which do not allow amounts of calcium or aluminum in the GI tract may combine with sufficient time for absorption; and immobilization. In people daily through the intestines (in mucosal and biliary secretions and with acute or chronic renal failure, phosphorus intake is restricted sloughed intestinal cells). Functions Functions Phosphorus, most of which is located intracellularly as the phos- • Calcium participates in many metabolic processes, including phate ion, performs many metabolic functions: the regulation of: • It is an essential component of deoxyribonucleic acid, • Cell membrane permeability and function ribonucleic acid, and other nucleic acids in body cells. Thus, • Nerve cell excitability and transmission of impulses (eg, it is it is required for cell reproduction and body growth. This re- • Conduction of electrical impulses in the heart action also prevents buildup of excessive amounts of free • Blood coagulation and platelet adhesion processes fatty acids. When excess hydrogen ions are present • Catecholamine release from the adrenal medulla, Release of chemical mediators (eg, histamine from mast cells) in kidney tubules, phosphate combines with them and allows • Calcium is required for building and maintaining bones and their excretion in urine. Bone calcium is composed mainly of calcium phosphate tained by the kidneys and contributes to alkalinity of body and calcium carbonate. Although there are other buffering systems in the amount of calcium is available for exchange with serum. This body, failure of the phosphate system leads to metabolic aci- acts as a reserve supply of calcium. Calcium is constantly shift- dosis (retained hydrogen ions or acid and lost bicarbonate ing between bone and serum as bone is formed and broken ions or base). When serum calcium levels become low, calcium moves • It is necessary for cellular use of glucose and production of into serum. Increased daily amounts are needed by growing children (1200 mg), pregnant or lactating women (1200 mg), and Requirements and Sources postmenopausal women who do not take replacement estrogens Daily requirements for phosphorus are approximately 800 mg for (1500 mg to prevent osteoporosis). Good 8-oz glasses of milk daily contain approximately the amount sources are milk and other dairy products, meat, poultry, fish, eggs, needed by healthy adults. There is little risk of phosphorus deficiency with an ad- body because milk also contains lactose and vitamin D, both of equate intake of calcium and protein. It may be caused by inadequate intake of calcium poor memory, headache, and drowsiness. Severe hypercalcemia and vitamin D, numerous disorders (eg, diarrhea or malabsorption may produce lethargy, syncope, disorientation, hallucinations, syndromes that cause inadequate absorption of calcium and vitamin coma, and death. Other signs and symptoms include weakness and D, hypoparathyroidism, renal failure, severe hypomagnesemia, decreased tone in skeletal and smooth muscle, dysphagia, polyuria, hypermagnesemia, acute pancreatitis, rhabdomyolysis, tumor lysis polyphagia, and cardiac dysrhythmias. In addition, calcium may be syndrome, vitamin D deficiency), and several drugs (eg, cisplatin, deposited in various tissues, such as the conjunctiva, cornea, and cytosine arabinoside, foscarnet, ketoconazole, pentamidine, and kidneys. Calcium deposits in the kidneys (renal calculi) may lead to agents used to treat hypercalcemia). First, inability to Osteoporosis excrete phosphate in urine leads to accumulation of phosphate in Osteoporosis is characterized by decreased bone density (os- the blood (hyperphosphatemia). Because phosphate levels are in- teopenia) and weak, fragile bones that often lead to fractures, pain, versely related to calcium levels, hyperphosphatemia induces and disability. Second, when kidney function is impaired, vitamin ture sites are the vertebrae of the lower dorsal and lumbar spines, D conversion to its active metabolite is impaired. Risk factors include female sex, advanced age, small stature, Clinical manifestations are characterized by increased neuro- lean body mass, white or Asian race, positive family history, low muscular irritability, which may progress to tetany. Tetany is char- calcium intake, menopause, sedentary lifestyle, nulliparity, smok- acterized by numbness and tingling of the lips, fingers, and toes; ing, excessive ingestion of alcohol or caffeine, high protein in- twitching of facial muscles; spasms of skeletal muscle; carpope- take, high phosphate intake, hyperthyroidism, and chronic use dal spasm; laryngospasm; and convulsions. In young children, of certain medications (eg, corticosteroids, phenytoin). Post- hypocalcemia may be manifested by convulsions rather than menopausal women who do not take estrogen replacement ther- tetany and erroneously diagnosed as epilepsy.

cheap 17.5 mg lisinopril with mastercard

Discuss factors influencing selection and effects discount lisinopril 17.5 mg amex, and nursing process implications of dosage of aminoglycosides buy lisinopril 17.5mg fast delivery. Critical Thinking Scenario George Masury lisinopril 17.5 mg without prescription, accompanied by his wife Jennie, visits his primary care provider complaining of upper respira- tory symptoms. George and Jennie have been married for 52 years and Jennie has always cared for George when he was sick and helped make decisions for him. George is hard of hearing, has some forgetfulness, and does not talk very much. Reflect on: How you will include George and Jennie in the teaching session. Teaching strategies to individualize for hearing deficits and memory deficits. OVERVIEW ual drugs, with routes of administration and dosage ranges, are listed in the Drugs at a Glance tables. The aminoglycosides have been widely used to treat serious gram-negative infections for many years. The quinolones are AMINOGLYCOSIDES also older drugs originally used only for treatment of urinary tract infections (see Chap. The fluoroquinolones are Aminoglycosides are bactericidal agents with similar pharma- synthesized by adding a fluorine molecule to the quinolone cologic, antimicrobial, and toxicologic characteristics. This addition increases drug activity against gram- used to treat infections caused by gram-negative microorgan- negative microorganisms, broadens the antimicrobial spec- isms such as Pseudomonas and Proteus species, Escherichia trum to include several other microorganisms, and allows use coli, and Klebsiella, Enterobacter, and Serratia species. General character- These drugs are poorly absorbed from the gastrointestinal istics, mechanisms of action, indications for and contraindica- (GI) tract. Thus, when given orally, they exert local effects in tions to use, nursing process implications, and principles of the GI tract. They are well absorbed from intramuscular injec- therapy for these drugs are described in this chapter. Individ- tion sites and reach peak effects in 30 to 90 minutes if circula- 527 528 SECTION 6 DRUGS USED TO TREAT INFECTIONS Drugs at a Glance: Aminoglycosides Routes and Dosage Ranges Generic/Trade Name Characteristics Adults Children Amikacin (Amikin) Retains a broader spectrum of antibac- IM, IV 15 mg/kg q24h, 7. Hepatic coma PO 4–12 g daily in Used topically, often in combination divided doses with other drugs, to treat infections of the eye, ear, and skin (burns, wounds, ulcers, dermatoses) When used for wound or bladder irriga- tions, systemic absorption may occur if the area is large or if drug concen- tration exceeds 0. Netilmicin (Netromycin) Similar to gentamicin in antimicrobial IM, IV 4–6. However, systemic absorption may occur in the presence of inflamma- tory or ulcerative bowel disease. CHAPTER 35 AMINOGLYCOSIDES AND FLUOROQUINOLONES 529 Drugs at a Glance: Aminoglycosides (continued) Routes and Dosage Ranges Generic/Trade Name Characteristics Adults Children Streptomycin May be used in a four- to six-drug IM 15 mg/kg/d (maximum 1 g) or IM 20–40 mg/kg/d in two divided regimen for treatment of multidrug- 25–30 mg/kg two or three doses, q12h (maximum dose, resistant tuberculosis times weekly (maximum 1. They accumulate in high concentrations in the kidney effects occur within 30 to 60 minutes. They are poorly distributed to the central nervous 4 hours with normal renal function. After parenteral administration, aminoglycosides are widely Injected drugs are not metabolized; they are excreted un- distributed in extracellular fluid and reach therapeutic levels changed in the urine, primarily by glomerular filtration. Oral in blood, urine, bone, inflamed joints, and pleural and ascitic drugs are excreted in feces. Drugs at a Glance: Fluoroquinolones Generic/Trade Name Characteristics Routes and Dosage Ranges Cinoxacin (Cinobac) 1. Used only for UTI PO 1 g daily in two to four divided doses for 7–14 d 2. Effective against most gram-negative bacteria that commonly cause UTI (Escherichia coli, Klebsiella, Enterobacter, Proteus) Ciprofloxacin (Cipro) 1. Effective in respiratory, urinary tract, gastro- PO 250–750 mg q12h intestinal tract, and skin and soft tissue infec- IV 200–400 mg q8–12h tions as well as sexually transmitted diseases caused by chlamydiae and gonor- rhea organisms 2. Used as one of four to six drugs in treatment of multidrug-resistant tuberculosis Enoxacin (Penetrex) Used only for UTI and uncomplicated gonorrhea UTI, PO 200–400 mg q12h for 7–14 d Gonorrhea, PO 400 mg as a single dose Gatifloxacin (Tequin) Indicated for pneumonia, bronchitis, sinusitis, skin PO, IV infusion 400 mg once daily and soft tissue infections, urinary infections, Give IV dose over 60 minutes; avoid rapid pyelonephritis, and gonorrhea administration Levofloxacin (Levaquin) A broad-spectrum agent effective for treatment of PO, IV 250–750 mg once daily. Infuse IV dose slowly bronchitis, cystitis, pneumonia, sinusitis, skin and over 60 min skin structure infections, and pyelonephritis Lomefloxacin (Maxaquin) Approved for bronchitis, urinary infections, and PO 400 mg once daily transurethral surgical procedures Preoperatively, PO 400 mg as a single dose, 1–6 h before surgery Moxifloxacin (Avelox) Indicated for pneumonia, sinusitis, bronchitis, skin PO, IV 400 mg once daily. Infuse IV dose slowly over and soft tissue infections 60 min Norfloxacin (Noroxin) Used only for UTI and uncomplicated gonorrhea PO 400 mg twice daily Ofloxacin (Floxin) See ciprofloxacin, above PO, IV 200–400 mg q12h for 3–10 d Gonorrhea, PO 400 mg as a single dose Sparfloxacin (Zagam) Indicated for community-acquired pneumonia caused PO 400 mg as loading dose, then 200 mg once daily by Chlamydia pneumoniae, Streptococcus pneu- for 10 d moniae, or Hemophilus influenzae and acute bac- Renal impairment (creatinine clearance terial exacerbations of chronic bronchitis caused <50 mL/min), PO 400 mg as loading dose, by above organisms, Klebsiella pneumoniae, or then 200 mg q48h for a total of 9 d of therapy Staphylococcus aureus UTI, urinary tract infection. These are discussed in Chapters 65 and 66, Aminoglycosides penetrate the cell walls of susceptible bac- respectively.

discount lisinopril 17.5 mg on-line

8 of 10 - Review by D. Kaffu
Votes: 124 votes
Total customer reviews: 124

Design ideas from